IIBR-100

N/A

Report date: 2024/02/01 17:55:23

Base Information

Drug NameIIBR-100
Drug Alias NamerVSV-SARS-CoV-2-S Vaccine (Israel Institute for Biological Research)BriLife™ COVID vaccineBriLife™ vaccinerVSV-Sars-CoV2 vaccine (Israel Institute for Biological Research)IIBR-100 +[6] 
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Recombinant vector vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIsrael Institute for Biological Research
China Registration ClassN/A

Develop Information

Active CompaniesIsrael Institute for Biological Research
Inactive CompaniesNRx Pharmaceuticals Inc
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A